We are live on ! Find out more
SRTS icon

Sensus Healthcare

16 hedge funds and large institutions have $9.89M invested in Sensus Healthcare in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% less ownership

Funds ownership: 10.94%10.81% (-0.13%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

21% less capital invested

Capital invested by funds: $12.6M → $9.89M (-$2.68M)

30% less funds holding

Funds holding: 2316 (-7)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
16
Holders Change
-7
Holders Change %
-30.43%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
5
Closed
10
Calls
Puts
Net Calls
Net Calls Change

SRTS Hedge Fund Activity: Q2 2019 in Review

16 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2019, worth a combined $9.89M — down 21% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of SRTS and 3 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Heartland Advisors, adding an estimated $1.32M. The largest seller was EAM Investors, exiting entirely with an estimated $490K sold.

  • 16 institutional investors held Sensus Healthcare (SRTS) as of Q2 2019, down from 23 in Q1 2019.
  • Funds reported $9.89M of Sensus Healthcare stock for Q2 2019, down 21% quarter-over-quarter.
  • 3 funds opened new Sensus Healthcare positions in Q2 2019 and 10 closed out, a net change of -7 holders.
  • The largest Sensus Healthcare buyer in Q2 2019 was Heartland Advisors, an estimated $1.32M added.
  • The largest Sensus Healthcare seller in Q2 2019 was EAM Investors, an estimated $490K sold.

Based on aggregated 13F filings for Q2 2019.